patients primary recurrent glioma brain irradiated wholely heavy charged particle beams university california lawrence berkeley laboratory phase clinical trial northern california oncology group course trial treatment techniques developed tumor doses escalated order obtain data normal brain toxicity response malignant glioma brain toxicity acceptable low level brain injury survival tumor control approximately historical results glioma brain dose escalation planned possible trial combined modality therapy thirty ii